Novo Nordisk Q3 profit surpasses USD 1.8bn

The Danish pharmaceutical giant has revealed net profits of DKK 12bn (USD 1.8bn) for the third quarter of 2021, and DKK 36.8bn (USD 5.7bn) for the first nine months of the year.

Photo: Novo Nordisk / PR

Novo Nordisk has generated a DKK 12bn (USD 1.8bn) profit in the third quarter of 2021, significantly more than for the same period last year, where the bottom line was DKK 10.3bn (USD 1.6bn), according to its report released on Wednesday morning.

For the first nine months of the year, net profit totals DKK 36.8bn (USD 5.7bn) compared to DKK 32.8bn (USD 5.1bn) at the same point last year. That is an increase of 12 percent, the report states.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs